Citigroup Inc Exact Sciences Corp Transaction History

Citigroup Inc

$196 Billion
Q2 2025

A detailed history of Citigroup Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Citigroup Inc holds 233,162 shares of EXAS stock, worth $15.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

233,162

Previous 1,281,905 81.81%

Holding current value

$15.4 Million

Previous $55.5 Million 77.67%

% of portfolio

0.01%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$40.31 - $58.08 $42.3 Million - $60.9 Million	-1,048,743 Reduced 81.81%	233,162 $12.4 Million
Q1 2025 May 12, 2025	BUY	$43.04 - $58.51 $21.3 Million - $29 Million	495,780 Added 63.07%	1,281,905 $55.5 Million
Q4 2024 Feb 12, 2025	BUY	$49.33 - $71.97 $22.4 Million - $32.7 Million	454,464 Added 137.03%	786,125 $44.2 Million
Q3 2024 Nov 12, 2024	SELL	$42.43 - $70.83 $2.21 Million - $3.69 Million	-52,145 Reduced 13.59%	331,661 $22.6 Million
Q2 2024 Aug 12, 2024	SELL	$41.33 - $74.26 $16 Million - $28.7 Million	-386,578 Reduced 50.18%	383,806 $16.2 Million
Q1 2024 May 10, 2024	BUY	$56.27 - $73.77 $33.2 Million - $43.5 Million	589,281 Added 325.38%	770,384 $53.2 Million
Q4 2023 Feb 09, 2024	BUY	$59.06 - $75.72 $1.14 Million - $1.46 Million	19,253 Added 11.9%	181,103 $13.4 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $2.55 Million - $3.84 Million	38,726 Added 31.45%	161,850 $11 Million
Q2 2023 Aug 10, 2023	SELL	$62.68 - $95.05 $6.05 Million - $9.17 Million	-96,470 Reduced 43.93%	123,124 $11.6 Million
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $1.78 Million - $2.67 Million	37,677 Added 20.71%	219,594 $14.9 Million
Q4 2022 Feb 09, 2023	SELL	$30.35 - $53.15 $3.46 Million - $6.06 Million	-114,074 Reduced 38.54%	181,917 $9.01 Million
Q3 2022 Nov 10, 2022	BUY	$31.97 - $49.37 $2.24 Million - $3.46 Million	69,999 Added 30.97%	295,991 $9.62 Million
Q2 2022 Aug 10, 2022	SELL	$35.61 - $76.23 $183,320 - $392,432	-5,148 Reduced 2.23%	225,992 $8.9 Million
Q1 2022 May 12, 2022	BUY	$57.56 - $82.54 $2.48 Million - $3.56 Million	43,091 Added 22.91%	231,140 $16.2 Million
Q4 2021 Feb 10, 2022	BUY	$72.5 - $100.68 $673,235 - $934,914	9,286 Added 5.19%	188,049 $14.6 Million
Q3 2021 Nov 10, 2021	BUY	$90.24 - $124.05 $16.1 Million - $22.2 Million	178,763 New	178,763 $17.1 Million

Others Institutions Holding EXAS

# of Institutions

655

Shares Held

159M

Call Options Held

1.43M

Put Options Held

2.35M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.7B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account